Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jamie L. Reynoso Insider Profile
4 Followers
Jamie L. Reynoso, CEO, Medicare Advantage at Clover Health Investments, holds 3.35M shares in Clover Health Investments (Ticker: CLOV).
Jamie L. Reynoso has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jamie L. Reynoso's holdings
Insider Roles
CEO, Medicare Advantage
Roles that Jamie L. Reynoso holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jamie L. Reynoso
Jamie L. Reynoso's Trading History
List of latest transactions for each holding click on a transaction to see Jamie L. Reynoso's performance on stock
You May Also Like
Jamie L. Reynoso insider profile FAQ
What is the percentage of profitable transactions made by Jamie L. Reynoso?
The percentage of profitable transactions made by Jamie L. Reynoso is ―.
What is the average return per transaction made by Jamie L. Reynoso?
The average return per transaction made by Jamie L. Reynoso is ―.
What stocks does Jamie L. Reynoso hold?
Jamie L. Reynoso holds: CLOV stocks.
What was Jamie L. Reynoso’s latest transaction?
Jamie L. Reynoso latest transaction was an Uninformative Sell of $486.37K.
What was Jamie L. Reynoso's most profitable transaction?
Jamie L. Reynoso’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jamie L. Reynoso's role in Clover Health Investments?
Jamie L. Reynoso's role in Clover Health Investments is CEO, Medicare Advantage.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.